Discover
MRKR
Marker Therapeutics, Inc.
1.18
2 x 0.86
2 x 1.53
bid
ask
+
0.00
0.00%
2 @ 04:10 PM
1.18 +0.00 (0.00%)
| Ytd | -20.81% | |
| 1y | 22.92% |
1.17
day range
1.23
0.85
52 week range
2.19
| Open | 1.19 | Prev Close | 1.18 | Low | 1.17 | High | 1.23 | Mkt Cap | 19.67M |
| Vol | 47.27K | Avg Vol | 65.80K | EPS | -0.38 | P/E | N/A | Forward P/E | -2.34 |
| Beta | 1.49 | Short Ratio | 1.55 | Inst. Own | 22.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.26 | 200-d Avg | 1.44 | 1yr Est | 19.00 |
| Income Statement | |||
| Operating Expenses | 2.62M | ||
| Research and Development Expense | 1.48M | ||
| Selling, General and Administrative Expense | 1.14M | ||
| Operating Income | -2.62M | ||
| Net Income | -1.83M | ||
| Net Income Common Stock | -1.83M | ||
| Net Income Common Stock (USD) | -1.83M | ||
| Consolidated Income | -1.83M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -1.83M | ||
| Earning Before Interest & Taxes (USD) | -1.83M | ||
| Weighted Average Shares | 19.31M | ||
| Weighted Average Shares Diluted | 19.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.92M | ||
| Cash and Equivalents (USD) | 11.92M | ||
| Trade and Non-Trade Receivables | 1.62M | ||
| Current Assets | 14.59M | ||
| Total Assets | 14.59M | ||
| Current Liabilities | 2.42M | ||
| Total Liabilities | 2.42M | ||
| Accumulated Retained Earnings (Deficit) | -464.19M | ||
| Shareholders Equity | 12.17M | ||
| Shareholders Equity (USD) | 12.17M | ||
| Deferred Revenue | 591.31K | ||
| Trade and Non-Trade Payables | 1.83M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.72M | ||
| Net Cash Flow from Operations | -3.72M | ||
| Share Based Compensation | 195.74K | ||